https://ipharmag.com/article/stopping-ozempic-glp1-cardiovascular-risk iPharmag en 2026-09-23T04:06:41+00:00 Stopping Ozempic-Type Drugs May Undo Their Heart Benefits, a Large Study Finds https://ipharmag.com/article/long-covid-dopamine-neurons-brain-fog-pet iPharmag en 2026-09-23T04:06:41+00:00 Brain Scans Point to a Physical Cause of Long-COVID Brain Fog: Lost Dopamine Neurons https://ipharmag.com/article/celldex-barzolvolimab-urticaria-anaphylaxis-safety iPharmag en 2026-09-23T04:06:41+00:00 Strong Results, Shaky Stock: A Hives Drug’s Safety Signal Rattles Investors https://ipharmag.com/article/amgen-dazodalibep-sjogrens-cd40l-phase3 iPharmag en 2026-09-23T04:06:41+00:00 Amgen Drug Hits Its Goals in Sjögren’s Disease, a Common Autoimmune Illness With No Approved Treatment https://ipharmag.com/article/aacr-us-cancer-mortality-down-35-percent iPharmag en 2026-09-23T04:06:41+00:00 U.S. Cancer Deaths Have Fallen 35% Since 1991, Saving 4.8 Million Lives https://ipharmag.com/article/sars-cov-2-orf8-macrophages-lung-inflammation iPharmag en 2026-09-22T01:57:08+00:00 Scientists Find How a SARS-CoV-2 Protein Turns the Immune System Against the Lungs https://ipharmag.com/article/lilly-inluriyo-verzenio-esr1-breast-cancer-approval iPharmag en 2026-09-22T01:57:08+00:00 FDA Approves an All-Oral Combo That Doubles Progression-Free Time in a Breast Cancer Subtype https://ipharmag.com/article/fda-galleri-multicancer-test-staff-no-major-concerns iPharmag en 2026-09-22T01:57:08+00:00 FDA Reviewers Raise No Major Concerns Over a Blood Test That Screens for Many Cancers https://ipharmag.com/article/drc-ebola-vaccination-health-workers-ervebo-outbreak iPharmag en 2026-09-22T01:57:08+00:00 Congo Starts Vaccinating Health Workers as Its Worst-Ever Ebola Outbreak Grows https://ipharmag.com/article/beacon-laru-zova-gene-therapy-xlrp-blindness-phase3 iPharmag en 2026-09-22T01:57:08+00:00 A Gene Therapy for an Inherited Blindness Just Passed Its Pivotal Test https://ipharmag.com/article/telix-itm-acquisition-radiopharmaceutical-2-35-billion iPharmag en 2026-09-21T15:11:24+00:00 Telix Bets Up to $2.35B on ITM to Build a Radiopharmaceutical Powerhouse https://ipharmag.com/article/maxialtrode-needle-thin-brain-implant-three-functions iPharmag en 2026-09-21T15:11:24+00:00 A Hair-Thin Brain Implant Can Record, Medicate and Stimulate All at Once https://ipharmag.com/article/kratom-7-oh-withdrawal-addiction-clinics-surge iPharmag en 2026-09-21T15:11:24+00:00 Addiction Clinics Report a Surge in Withdrawal From Potent Kratom Products https://ipharmag.com/article/fda-nonclinical-tests-animal-testing-alternatives-rule iPharmag en 2026-09-21T15:11:24+00:00 FDA Rewrites Its Rules to Make Room for Alternatives to Animal Testing https://ipharmag.com/article/calcium-vitamin-d-supplements-little-bone-benefit-review iPharmag en 2026-09-21T15:11:24+00:00 Millions Take Calcium and Vitamin D for Their Bones. A Big Review Finds Little Benefit